A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study will examine the biological fate of radioactive SB-751689 administered to healthy
males and healthy postmenopausal women. Subjects will receive a single oral dose of
radioactive SB-751689. Excreta and blood samples will be taken over the course of 7 days.
This study will help determine the major route of elimination of SB-751689 in humans. It will
also provide samples (blood, plasma, urine, and stools) for analysis of metabolites, if any.